In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).

Globally, we have remediated 99% of actionable* sleep therapy device registrations to date. Registration for affected CPAP and BiPAP devices in the US and Canada closed on December 31, 2024, and the US patient portal reduced operations on June 30, 2025.

*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.

Philips Respironics will communicate with homecare providers directly throughout the ventilation device remediation process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be done via your DME.

We have streamlined our portfolio to enable us to focus on programs that are best suited to changing market dynamics and will most effectively serve patients and customers in the future.

In 2022, Philips Respironics voluntarily updated the contraindication and warning labeling for masks with magnets. As an industry-leading practice, we strengthened the already present warnings and added contraindications for individuals who have, or are in close proximity to, a metallic implanted device.

Customers who have V60 and V60 Plus devices affected by Medical Device Corrections 2020-CC-HRC-002, 2020-CC-HRC-003 and 2021-CC-HRC-003 that have not yet been remediated will be contacted by an Philips Authorized Service Provider (ASP) to schedule an appointment to perform any open Field Correction Orders (FCOs).

Ozone and UV light cleaning products are not currently approved cleaning methods for sleep apnea devices, ventilators, or masks and should not be used.